Split History
ETFs Holding RKDA »    RKDA Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Arcadia Biosciences is a producer and marketer of plant-based health and wellness products. Co.'s wholly-owned subsidiary Arcadia Wellness, LLC, houses all of its consumer goods businesses, including main brands GoodWheat, Zola Coconut Water and ProVault Topical Pain Relief, as well as non-core brands SoulSpring and Saavy Naturals Body Care. Co.'s GoodWheat brand is a portfolio of non-GMO wheat-based consumer products, which increases the nutrient density directly in the primary grains and oils. Co.'s topical pain relievers are formulated to address performance concerns from everyday pain to skin protection. Co.'s SoulSpring products help rejuvenate and renew the mind, body, and soul. According to our RKDA split history records, Arcadia Biosciences has had 1 split.
RKDA split history picture
Arcadia Biosciences (RKDA) has 1 split in our RKDA split history database. The split for RKDA took place on January 24, 2018. This was a 1 for 20 reverse split, meaning for each 20 shares of RKDA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.

When a company such as Arcadia Biosciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the RKDA split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Arcadia Biosciences shares, starting with a $10,000 purchase of RKDA, presented on a split-history-adjusted basis factoring in the complete RKDA split history. RKDA split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/20/2015
End date: 09/30/2022
Start price/share: $155.80
End price/share: $0.53
Dividends collected/share: $0.00
Total return: -99.66%
Average Annual Total Return: -53.78%
Starting investment: $10,000.00
Ending investment: $33.87
Years: 7.37
Date Ratio
01/24/20181 for 20
RKDA is categorized under the Materials sector; below are some other companies in the same sector that also have a history of stock splits:

RKT Split History
RML Split History
ROCK Split History
ROG Split History
RPM Split History
RS Split History
RSC Split History
RTI Split History
RTK Split History
RUS Split History

Also explore: RKDA shares outstanding history

Email EnvelopeFree RKDA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

American Virtual Cloud Technologies, Inc. (AVCT)
Avenue Therapeutics, Inc. (ATXI)
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

RKDA Insider Buying

RKDA Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.